Roche to Buy InterMune for $8.3B, Adds Lung Drug

Aug. 25 (Bloomberg) -- Roche is strengthening its portfolio of medicines for respiratory ailments with an agreement to buy InterMune for $8.3 billion in cash. Olivia Sterns reports on “In The Loop.” (Source: Bloomberg)
How Financial Markets Blocked Fed's Inflation Fight
27:05 - Jacob Frenkel, chairman at JPMorgan Chase International, discusses the impact of monetary policy on inflation and explains why the Fed's attempts were blocked in the United States. He speaks on "Bloomberg Surveillance." (Source: Bloomberg)
  • The Last Audio Cassette Factory
  • The Myth of the Commodity Supercycle
  • Stock Meltdown: Explaining the Volatile Markets